Fifth Of Men Research Articles

Trends in the dynamics of morbidity and mortality from hypertension in the Republic of Kazakhstan from 2010 to 2019.

Aim: The purpose of the research is to study trends in the dynamics of morbidity and mortality from arterial hypertension in the Republic of Kazakhstan for 2010-2019. Materials and Methods: Due to the interdisciplinary nature of the study, a set of methods was used: analytical, graph-analytical, statistical, sociological, clinical and economic analysis, organizational experiment. Results: The survey of 318 hypertension patients highlighted a common profile: hypertensive men aged 45-59, smokers, alcohol drinkers, urban dwellers, married with children, industrially employed, physically active at their country house, and facing stress. Gender differences showed 74.4% of hypertensive women were over 50, while a fifth of men were under 45, with higher risk factors in men: smoking (1.87), alcohol (2.53), occupational hazards (2.76), and harsh climates (2.54). Conclusions: The analysis findings reveal noteworthy trends within the hypertension patient population in Kazakhstan. Despite a decline in hypertension prevalence and initial occurrences, along with reduced relative hospitalization rates between 2010 and 2019, mortality linked to hypertension-related causes and the occurrence of heart attacks have remained relatively steady in recent times.

Nationwide analysis of prehospital tranexamic acid for trauma demonstrates systematic bias in adherence to treatment guidelines: a retrospective cohort study.

Prehospital (PH) tranexamic acid (TXA) improves survival from trauma haemorrhage. Injury mechanism, physiology, and sex demographics vary with patient age. The authors hypothesised that these factors influence TXA guideline compliance and examined national trends in PH use to identify any systematic biases in bleeding management. The UK Trauma Audit and Research Network data for TXA eligible patients admitted to major trauma centres were divided into two cohorts: 2013-2015 ( n =32072) and 2017-2019 ( n =14974). Patients were stratified by PH, emergency department or no TXA use. Logistic regression models explored interaction between PH variables and TXA administration. Results are presented as odds ratios with a 95% CI. PH TXA use increased from 8% to 27% over time ( P <0.001). Only 3% of eligible patients who fell less than 2m received PH TXA versus 63% with penetrating injuries ( P <0.001). Older patients eligible for PH TXA were less likely to receive it compared to younger patients [≥65 years old: 590 (13%) vs. <65 years old: 3361 (33%), P <0.001]. There was a significant interaction between age and sex with fewer older women receiving PH TXA. In shocked patients, one third of females compared to a fifth of men did not receive TXA ( P <0.001). There was a decrease in PH TXA use as age increased ( P <0.001). Despite a threefold increase in use, treatment guidance for PH TXA is not universally applied. Older people, women, and patients with low energy injury mechanisms appear to be systematically under treated. Training and education for PH providers should address these potential treatment biases.

(077) Testosterone Therapy in Men on Active Surveillance for Prostate Cancer

Abstract Introduction The role of testosterone therapy (TTH) in men with prostate cancer (PC) is debated, especially in men on active surveillance (AS). Objective This study aimed to review our data on TTH in this population. Methods The study population consisted of (i) men with PC on active surveillance (ii) with two total T (TT) levels &amp;lt;300 ng/dL (iii) associated with symptoms (iii) performed using LCMS (v) conducted in an early morning fashion who (vi) pursued T therapy (TTH). TTH included exogenous (transdermal, intramuscular) and clomiphene citrate (CC) in the setting of low/low-normal LH levels. T lab work including PSA levels, were checked within 4 weeks of TTH initiation, every three months in the first year and every six months after that. Target TT level was the middle tertile of the normal reference range at our institution. We report on T and PSA levels in this group. Results 82 patients are included. Mean age = 64 ± 9 years. Median pre-TTH PSA levels were 4.6 [3.4, 6.7] ng/mL. Mean baseline TT levels were 305 ± 145 ng/dL. 19% of these men had a TT level &amp;lt;200 ng/dL. Median Gleason score (GS) was 6 with 90% 3+3, 9% 3+4 and 1% 4+3. Median duration on AS before TTH was 14 [1, 43] months. 45% received transdermal T, 19% intramuscular T and 36% CC. Post-TTH TT = 553 ± 268 ng/dL, PSA = 4.9 [3.2, 9.2] Median duration of TTH at last follow-up was 14 [1, 39] months. Median PSA change per patient was 0.3 [-0.9, 2.6] ng/mL, representing a median of 14 (-24, 70) % change in PSA per patient (p= 0.045). 42% had a decrease in PSA, 58% an increase. In 88% of men who experienced a rise in PSA, the PSA rose ≥10%. 50% of men on TTH who had a PSA level below 4 ng/dL rose above 4. 28% of men experienced a PSA level increase ≥1 ng/mL per year. In 18% of these men, TTH was stopped and definitive PC treatment was instituted. In men with ≤1 ng/mL per year increase in PSA, another 18% opted for definitive PC treatment. The most common reason for this was PSA anxiety. Conclusions In men with PC on AS treated with TTH, minimal changes in PSA were seen, with equal numbers of men experiencing a rise and a drop in PSA. About fifth of men ceased AS and proceeded to definitive therapy for their PC. Disclosure No

Short versus long course therapy in the treatment of febrile urinary tract infections in men based on serum PSA values

BackgroundFebrile urinary tract infections (fUTI) in men are frequently complicated with subclinical prostatic involvement, measured by a transient increase in serum prostate-specific-antigen (sPSA). The aim of this study was to evaluate recurrence rates in a 6-month follow-up period of 2-week versus 4-week antibiotic treatment in men with fUTI, based on prostatic involvement. Clinical and microbiological cure rates at the end-of-therapy (EoT) were also assessed. MethodsOpen label, not-controlled, prospective study. Consecutive men diagnosed of fUTI were included. Duration of therapy was 2 weeks for patients with a sPSA level <5mg/L (short duration therapy, SDT) or 4 weeks for PSA >5 mg/L (long duration therapy, LDT). ResultsNinety-one patients were included; 19 (20%) received SDT. Median age was 56.9 years (range 23-88). Bacteremia was present in 9.8% of patients (Escherichia coli was isolated in 91%). Both groups had similar demographic, clinical characteristics and laboratory findings. Median PSA levels were 2.3 mg/L in the SDT group vs 23.4 mg/L in the LDT group. In the 6-month visit, 26% of patients had achieved complete follow-up. Nonsignificant differences between groups were found neither in recurrence rates after 6 months (9% in SDT vs 10% in LDT) nor in clinical or microbiological cure rates at EoT (100% in SDT vs 95% in LDT and 95% in SDT vs 93% in LDT respectively). ConclusionsOne fifth of men with fUTI did not present apparent prostatic involvement. A 2-week regimen seems adequate in terms of clinical, microbiological cure and recurrence rates for those patients without PSA elevation.

Association between cardiovascular diseases and depressive symptoms in adults. A pooled analysis of population-based surveys: WOBASZ, NATPOL 2011, and WOBASZ II.

INTRODUCTION Psychosocial risk factors play an important role in the origins of cardiovascular risk. OBJECTIVES The aim of the study was to evaluate the prevalence of depressive symptoms (DSs) in relation to some sociodemographic characteristics and selected cardiovascular diseases (CVDs) and to assess the relationship between self‑reported CVDs and the severity of DSs. PATIENTS AND METHODS Three cross‑sectional population‑based surveys: WOBASZ (2003-2005), NATPOL 2011 (2011), and WOBASZ II (2013-2014) covered a total sample of 20 514 participants (9614 men and 10 900 women), aged 20 to 74 years, who all completed the Beck Depression Inventory. RESULTS One‑fifth of men and one‑third of women had DSs. The prevalence of DSs increased with age, was higher in unmarried persons and in individuals with a medical history of CVDs, and decreased with increasing education level. Individuals with DSs, both men and women, even those with borderline depression, had from 1.5- to more than 2‑fold higher odds of either coronary artery disease or arrhythmia, and 2- to almost 4‑fold higher chance of previous stroke in their medical history. CONCLUSIONS This study showed that DSs were a frequently observed condition in the general Polish population including patients with CVDs. We also demonstrated that there is a relationship between self‑reported CVDs and severity of DSs regardless of age, marital status, education, and concomitant disorders.

Analysis of prevalence and prognostic implications of early versus delayed PSA declines during radium-223 (Ra223) treatment among men with metastatic castration-resistant prostate cancer (mCRPC).

117 Background: Ra233 is a well-tolerated, bone-seeking alpha emitter that prolongs the survival of men with mCRPC. Since there is a lack of validated biomarkers useful for disease monitoring during Ra223 therapy, we sought to characterize prostate-specific antigen (PSA) response patterns within a retrospective cohort study of real-world Ra223 treatment in four cancer centres across Ontario. Methods: Of 198 patients (pts) overall, 64 were not included due to incomplete data. The remaining 134 pts were grouped into (i) early PSA responders with a ≥30% PSA decrease (PSA30) within 12 weeks of treatment start, (ii) pts with an initial PSA flare followed by decreasing PSA, and (iii) non-responders. We analyzed the overall survival (OS) of these three cohorts using the Kaplan-Meier method and log-rank testing. Results: PSA30 responses were rare (n = 11; 8.2%), PSA flares were seen in 20.2% of pts (n = 27), but the majority of pts did not achieve a PSA response (n = 96; 71.7%). Of the pts identified as having a PSA flare, 11/27 (40.7%) presented with a post-flare PSA decrease below baseline, whereas in 16/27 (59.3%) the PSA decreased below the flare peak but not below baseline. 5/27 (18.5%) pts with a PSA flare achieved a PSA30. The median OS was not reached, 15.8 months and 14.7 months in responders, flare pts and non-responders, respectively (p &gt; 0.05). Similarly, one year OS was 90.9%, 67.7% and 63.9% in responders, flare pts and non-responders. Conclusions: PSA flares are seen in one fifth of men undergoing Ra223 therapy for mCRPC. Despite delayed PSA declines of varying degrees, the survival of PSA flare pts is comparable to men without any PSA decline.

Management of erectile dysfunction after prostate cancer treatment: cross-sectional surveys of the perceptions and experiences of patients and healthcare professionals in the UK

ObjectivesErectile dysfunction (ED) is known to be a common consequence of radical treatment for prostate cancer (PCa) but is often under-reported and undertreated. This study aimed to explore how ED...

Dysfunctional breathing: what do we know?

ABSTRACTDysfunctional breathing (DB) is a respiratory condition characterized by irregular breathing patterns that occur either in the absence of concurrent diseases or secondary to cardiopulmonary diseases. Although the primary symptom is often dyspnea or “air hunger”, DB is also associated with nonrespiratory symptoms such as dizziness and palpitations. DB has been identified across all ages. Its prevalence among adults in primary care in the United Kingdom is approximately 9.5%. In addition, among individuals with asthma, a positive diagnosis of DB is found in a third of women and a fifth of men. Although DB has been investigated for decades, it remains poorly understood because of a paucity of high-quality clinical trials and validated outcome measures specific to this population. Accordingly, DB is often underdiagnosed or misdiagnosed, given the similarity of its associated symptoms (dyspnea, tachycardia, and dizziness) to those of other common cardiopulmonary diseases such as COPD and asthma. The high rates of misdiagnosis of DB suggest that health care professionals do not fully understand this condition and may therefore fail to provide patients with an appropriate treatment. Given the multifarious, psychophysiological nature of DB, a holistic, multidimensional assessment would seem the most appropriate way to enhance understanding and diagnostic accuracy. The present narrative review was developed as a means of summarizing the available evidence about DB, as well as improving understanding of the condition by researchers and practitioners.

A population-based study of the clinical utility of 18F\u2013choline PET/CT for primary metastasis staging of high-risk prostate cancer

BackgroundThe clinical utility of 18F–choline positron emission tomography fused with computed tomography (PET/CT) in all men with high-risk prostate cancer is still uncertain, because of selection of patients in previous studies. Prohibitive costs are one reason for PET/CT not being recommended for primary metastasis staging in European or American guidelines. The purpose of this retrospective study was to assess the clinical utility of in for primary metastasis staging in as complete a population as possible of men with high-risk prostate cancer. A secondary purpose was to evaluate whether a subgroup of these men could omit metastasis staging.ResultsIn total 410 men were identified with high-risk prostate cancer. After exclusions, 317 men were initially considered for curative treatment; 213 (67%) had a choline PET/CT, with 43 men (20%) having positive findings. The risk of lymph node metastasis according to the Briganti nomogram showed a good discrimination between men with low and high risk of positive scans. Among the 35% of men with <20% risk according to the nomogram, only 1% had a positive scan, compared to 30% positive scans among the men who had higher risk.Conclusion18F–choline PET/CT detects suspected metastases in one fifth of men with high-risk prostate cancer and should be considered for routine use. For men with <20% risk of metastasis according to the Briganti nomogram, imaging for metastasis staging might be omitted.

The Role of Alcohol on Antiretroviral Therapy Adherence Among Persons Living With HIV in Urban India.

The purpose of this study was to estimate the prevalence of alcohol use among men living with HIV on antiretroviral therapy (ART) and examine the association of alcohol use and psychosocial variables on ART adherence. The study was a cross-sectional survey supplemented by medical records and qualitative narratives as a part of the initial formative stage of a multilevel, multicentric intervention and evaluation project. A screening instrument was administered to men living with HIV (n = 3,088) at four ART Centers using the Alcohol Use Disorders Identification Test-consumption questions (AUDIT-C) to determine alcohol use for study eligibility. Alcohol screening data were triangulated with medical records of men living with HIV (n = 15,747) from 13 ART Centers to estimate alcohol consumption among men on ART in greater Mumbai. A survey instrument to identify associations between ART adherence and alcohol, psychosocial, and contextual factors was administered to eligible men living with HIV (n = 361), and in-depth interviews (n = 55) were conducted to elucidate the ways in which these factors are manifest in men's lives. Nearly one fifth of men living with HIV on ART in the Mumbai area have consumed alcohol in the last 30 days. Non-adherence was associated with a higher AUDIT score, consumption of more types of alcohol, and poorer self-ratings on quality of life, depression, and external stigma. The qualitative data demonstrate that non-adherence results from avoiding the mixing of alcohol with medication, forgetfulness when drinking, and skipping medication for fear of disclosure of HIV status when drinking with friends. As the demand for ART expands, Indian government programs will need to more effectively address alcohol to reduce risk and maintain effective adherence.

Vegetable consumption among adults in Germany.

Vegetables are part of a healthy diet and can help prevent various chronic diseases. According to the GEDA 2014/2015-EHIS study, 40.4% of women and 23.9% of men eat vegetables on a daily basis. The proportion of women who eat vegetables every day increases with age: from 31.9% of 18- to 29-year-olds to 48.3% of women aged 65 and above. Around one fifth of men under the age of 65 eat vegetables daily; this increases to 35.9% of men aged 65 or above. Across all age groups, women with higher levels of education are more likely to eat vegetables on a daily basis; the same can only be said about men in the 45 to 64 age group. Finally, women and men living in Saxony are most likely to eat vegetables every day; however, the differences between the federal states are marginal.

Current issues of diagnosis and treatment of osteoporosis in men in general practice

The author revises the latest evidence in the literature regarding managing of osteoporosis in men. Osteoporosis is an important under-recognized problem threatening men. Among people over 50 years of age, a fifth of men will suffer a fragility fracture during their remaining lifetime. The leading risk factors of male osteoporosis are genetic predisposition, low sex hormones and secondary osteoporosis. The latter comprises up to 40% of all male osteoporosis cases. The most common causes of secondary osteoporosis in men are alcohol abuse, endogenic and exogenic hypercortisolism and hypogonadism. Treatment of the underlying disease may result in BMD increase and probably fracture risk improvement. Bisphosphonates (alendronate, risedronate and zoledronic acid), denosumab and teriparatide are approved for treatment of male osteoporosis. Non-pharmacological treatment including avoiding smoking and excessive drinking, health lifestyle and a diet rich in bone-healthy nutrients should also be considered.

Rupture of Abdominal Aortic Aneurysms in Patients Under Screening Age and Elective Repair Threshold

The objective of this study was to identify the proportion of abdominal aortic aneurysm ruptures that occur before the screening age or threshold diameter for operative repair is reached. The study was a retrospective analysis of RAAA patients including all RAAA patients admitted to Helsinki (HUH) and Tampere University Hospitals (TaUH) during 2002-2013. The data for age, gender, and comorbidities were collected from vascular registry and patient records. Computed tomography images taken at the time of admission were used for the measurement of maximum anteroposterior (AP) aneurysm diameter at the time of rupture. Age and diameter data were compared with risk factors. A total of 585 patients diagnosed with RAAA were admitted to the two hospitals during the 12 year period. The mean age at the time of rupture was 73.6 years (SD 9.5, range 42-96 years). 18.3% of patients were under 65: 21.4% of men and 3.0% of women. Men were on average 8 years younger than women. The odds ratio (OR) for rupture before 65 years of age for smokers was 2.1 compared with non-smokers, and 28.4% of smokers were under 65 at the time of rupture. Of all RAAA patients, 327 had a computed tomography scan confirming rupture. The mean AP diameter of the aneurysm was 75.6 mm (SD 15.8, range 32-155 mm). The mean size was significantly lower in women than in men (70.5 vs. 76.8, p = .005). The data from this study show that a fifth of men would not make it to the screening age of 65 before AAA rupture, the proportion being even larger in active smokers. The data from this study also supports the previous finding that aneurysm size at the time of rupture is significantly smaller in women.

Determinants of long term treatment response following intra-articular steroid therapy in knee OA

Determinants of long term treatment response following intra-articular steroid therapy in knee OA

MP51-05 DEFINING THE INCIDENCE OF POLYCYTHEMIA IN MEN USING INTRAMUSCULAR TESTOSTERONE SUPPLEMENTATION

You have accessJournal of UrologySexual Function/Dysfunction/Andrology: Evaluation II1 Apr 2015MP51-05 DEFINING THE INCIDENCE OF POLYCYTHEMIA IN MEN USING INTRAMUSCULAR TESTOSTERONE SUPPLEMENTATION Serkan Deveci, Patrick Teloken, Keith O'Brien, Patricia Guhring, Marilyn Parker, Joseph Narus, and John P. Mulhall Serkan DeveciSerkan Deveci More articles by this author , Patrick TelokenPatrick Teloken More articles by this author , Keith O'BrienKeith O'Brien More articles by this author , Patricia GuhringPatricia Guhring More articles by this author , Marilyn ParkerMarilyn Parker More articles by this author , Joseph NarusJoseph Narus More articles by this author , and John P. MulhallJohn P. Mulhall More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2015.02.1742AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Polycythemia (PCT) is well-recognized adverse effect of testosterone supplementation. However, widely disparate rates exist in the literature (2-24%) based on varied definitions of PCT and modality of T supplementation. We attempted to determine the rate of PCT in patients in our intramuscular testosterone (IMT) program. METHODS Symptomatic men with two low total T (TT) levels (<350 ng/dl), using IMT for at least 6 months comprised the study cohort. Men used 200mg IM every 2 weeks and had peak (day 1-2) and trough T (day 13-14) levels checked after two cycles, and every 6 months. PCT was defined as hematocrit (HCT) ≥52%. Patients were excluded from IMT if they had baseline HCT >48%. A multivariate model was constructed to define predictors of PCT development. Factors assessed included: patient age, mean BMI, cigarette smoking history, baseline HCT, mean per patient peak TT level, mean per patient trough TT level, RESULTS 176 men were analyzed. 24% were diabetic, 48% prior or current cigarette smokers. At baseline, mean TT = 224±104 ng/dl. mean HCT = 38±6%, mean BMI = 32±6. Mean duration on IMT = 17±23 months. Mean peak TT level = 1164±240 ng/dl, mean trough TT level = 324±180 ng/dl. Mean HCT for entire cohort on IMT = 44±9 (39-57)%, representing a mean per patient change of 4.7±3.9 (2-11)%. 17% met the definition of HCT on IMT with a mean HCT = 54.2±1.8%. 23/30 patients with PCT developed it after 6 months on IMT. Factors found to be a predictor on multivariate analysis are listed in the Tables 1and 2, however cigarette smoking was not a predictor. CONCLUSIONS Almost one fifth of men on IMT experience PCT. Most men appear to develop it after 6 months of treatment. Predictors of PCT development are higher baseline HCT and higher peak TT levels. Categorical Variables Factor Odds Ratio 95% CI P value Baseline HCT >45% 2.8 1.6-5.9 <0.01 Baseline HCT per % point increase 1.4 1.1-3.4 <0.05 Any peak >1000 1.9 1.4-7.3 <0.01 Any trough >600 1.07 1.0-2.2 0.06 Continuous Variables Factor r P value Baseline HCT 0.58 <0.01 Mean peak 0.62 <0.01 © 2015 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 193Issue 4SApril 2015Page: e621 Advertisement Copyright & Permissions© 2015 by American Urological Association Education and Research, Inc.MetricsAuthor Information Serkan Deveci More articles by this author Patrick Teloken More articles by this author Keith O'Brien More articles by this author Patricia Guhring More articles by this author Marilyn Parker More articles by this author Joseph Narus More articles by this author John P. Mulhall More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...

Dynamics of risk of fatal cardiovascular diseases evaluated with the SCORE scale in men with disorders of fat metabolism

In 141 apparently healthy working men aged 55 years (mean) we assessed body mass index (BMI), states of lipid, carbohydrate and purine metabolism, morphological and functional state of the cardiovascular system (transthoracic echocardiography), carotid artery intima-media complex (IMC) (ultrasound investigation). Ten year risk of fatal heart disease was also evaluated with the SCORE scale. Same examination of all 141 men was repeated in 3 years. At both examinations 50% of subjects had abnormalities of lipid metabolism. Among these subjects 50% had hypercholesterolemia while hypertriglyceridemia was registered in 7 men. In 3 years numbers of patients with hypertriglyceridemia and elevated low density lipoprotein cholesterol significantly decreased. Arterial hypertension (AH) at initial examination was found in about one fifth of men. After 3 years number of patients with AH did not significantly increase, but the structure of the disease changed: number of patients with stage 2 AH increased and of those with stage 1 AH decreased. Cardiovascular risk measured in accordance with the SCORE scale was moderate at initial examination but significantly increased after three years. Thus despite the fact that during 3-year follow-up the subjects maintained relatively stable body mass and parameters of lipid metabolism risk of occurrence of fatal cardiovascular complications increased probably due to the aging and presence of additional risk factors (low high density lipoprotein, IMC thickening). Ultrasound investigation revealed that the AH progression contributed to the development of left ventricular hypertrophy and increase of intima-media thickness of brachiocephalic arteries.

Major Cardiovascular Risk Factors for Menopausal and Non-menopausal Women Compared with Men of the Same Age in Mashhad, Iran

Background: Menopause refers to the cessation of menstruation due to hormonal changes and ovarian inactivity in women. These changes in hormone levels lead to various health consequences. This period of physiological changes usually starts in women with 40-50 years of age, and is characterized by the reduction of estrogen level. The mortality rate of premenopausal women, due to cardiovascular diseases (CVDs), is one fifth of men, though it rapidly increases after the menopause. Therefore, this descriptive study was conducted in order to determine the cardiovascular risk factors for menopausal and non-menopausal women in comparison with men of the same age. Methods: The study sample included patients referring to the cardiovascular department of Imam Reza Hospital, Mashhad, Iran. The subjects were divided into 4 groups: non-menopausal women (n=35), men of the same age (as the non-menopausal women, n=35), menopausal women (n=50), and men of the same age (as the menopausal women, n=50). All criteria related to major cardiovascular risk factors including systolic and diastolic blood pressure (SBP and DBP), cholesterol, triglyceride (TG), and low and high-density lipoprotein (LDL and HDL) were measured and compared in all four groups. In order to analyze the data, Fisher's exact test was carried out using SPSS version 16. Results: There was a significant difference between non-menopausal women and men of the same age with regard to high SBP and DBP, hypercholesterolemia, low HDL, and high LDL. However, no significant difference was observed among two groups, regarding high levels of TG. The menopausal women and men of the same age showed significant differences in terms of high SBP and low HDL. However, no differences were observed in DBP, hypercholesterolemia, hypertriglyceridemia, and high LDL. Conclusion: Both non-menopausal and menopausal women and men had significant differences in relation to high SBP and low HDL. But a significant difference regarding high DBP, hypercholesterolemia and high LDL was only seen in non-menopausal women and men.

Desire for Parenthood, Beliefs about Masculinity, and Fertility Awareness among Young Danish Men

Studies on fertility and family formation intentions among men are scarce. In the Nordic countries more than 90% of young, childless men desire children in the future. However, around one fifth of men remain permanently childless. The aim of this study was to gain insight into family formation intentions, fertility awareness, and beliefs about the link between fertility and masculinity among young Danish men. We conducted semi-structured qualitative interviews with nine young, childless men undergoing short term or long term further educational training. Data were analysed with a hermeneutic approach. All but one man wished to have children in the future. The men emphasized the importance of having genetically linked children and fatherhood was regarded as a central part of masculinity. We found no differences in family formation intentions or fertility awareness between men pursuing short or long term educational training. Only one man considered his own potential risk of male infertility while the remaining participants took their fertility for granted. Despite knowledge about the decline in female fertility with age, most participants preferred to have children beyond the age of optimal female fertility. Participants’ knowledge of assisted reproduction was limited and they substantially over-estimated the chance of a live birth after assisted reproduction. Despite widespread public discussion in Denmark about declining semen quality in the Danish population, the increasing number of children born as a result of assisted reproduction, and the adverse effect on fertility of increasing female age, the young men in this study had considerable fertility-related knowledge gaps.

Geriatric Hip Fractures – The Need for Co-Managed Care

Osteoporotic fragility fractures are a significant cause of morbidity for the geriatric population. One third of women and one fifth of men over 50 will sustain a fragility fracture in their lifetime [1]. In the United States alone, this adds up to an estimated 2 million fractures each year [1]. These numbers are expected to rise in future years as the baby boomer generation advances in age. Conservative estimates have the number of osteoporotic hip fractures increasing from 330,000 yearly (at present) to 550,000 by 2040 [2,3].

SP4-25 Population survey of semen quality in young Scottish men

IntroductionFor years concerns have been raised that male semen quality is declining globally, and that this is a birth cohort effect. However, there has been a degree of subject selection...